Skip to main content
SpringerLink
Log in

Oestrogens, progestogens and cardiovascular disease

  • Chapter
Hormones and Atherosclerosis

  • 49 Accesses

Abstract

Oestrogens are prescribed to women in two circumstances — as part of oral contraceptive preparations, or as postmenopausal hormone replacement therapy. Oestrogens may also be prescribed to men as part of the treatment of prostatic carcinoma or to lower plasma cholesterol. The relationship of oestrogens and, in the case of oral contraceptives, progestogens to cardiovascular disease has been studied in all these circumstances. This chapter will review the evidence of a relationship between these sex hormones and disease of the coronary or cerebral arteries. Oestrogens are also associated with venous thromboembolism but this will not be discussed here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stadel, B. V. (1981). Oral contraceptives and cardiovascular disease. N. Engl. J. Med., 305, 612 and 672

    Article  PubMed  CAS  Google Scholar 

  2. Vessey, M. P. (1980). Female hormones and vascular disease — an epidemiological overview. Br. J. Fam. Plan., 6, 1

    Google Scholar 

  3. Radford, D. J. and Oliver, M. F. (1973). Oral contraceptives and myocardial infarction. Br. Med. J., 3, 428

    Article  PubMed  CAS  Google Scholar 

  4. Mann, J. I., Vessey, M. P., Thorogood, M. and Doll, R. (1975). Myocardial infarction in young women with special reference to oral contraceptive practice. Br. Med J., 2, 241

    Article  PubMed  CAS  Google Scholar 

  5. Mann, J. I., Thorogood, M., Waters, W. E. and Powell, C. (1975). Oral contraceptives and myocardial infarction in young women: a further report. Br. Med. J., 3, 631

    Article  PubMed  CAS  Google Scholar 

  6. Mann, J. I. and Inman, W. H. W. (1975). Oral contraceptives and death from myocardial infarction. Br. Med. J., 2, 245

    Article  PubMed  CAS  Google Scholar 

  7. Mann, J. I., Inman, W. H. W. and Thorogood, M. (1976). Oral contraceptive use in older women and fatal myocardial infarction. Br. Med. J., 2, 445

    Article  PubMed  CAS  Google Scholar 

  8. Shapiro, S., Shone, D., Rosenberg, L., Kaufman, D. W., Stolley, P. D. and Miettinen, O. S. (1979). Oral contraceptive use in relation to myocardial infarction. Lancet, 1, 743

    Article  PubMed  CAS  Google Scholar 

  9. Jick, H., Dinan, B. and Rothman, K. J. (1978). Oral contraceptives and nonfatal myocardial infarction. J. Am. Med. Assoc., 239, 1403

    Article  CAS  Google Scholar 

  10. Petitti, D. B., Wingerd, J., Pellegrin, F. and Ramcharan, S. (1979). Risk of vascular disease in women. J. Am. Med. Assoc., 242, 1150

    Article  CAS  Google Scholar 

  11. Royal College of General Practitioners’ Oral Contraception Study (1981). Further analyses of mortality in oral contraceptive users. Lancet, 1, 541

    Google Scholar 

  12. Krueger, D. E., Ellenberg, S. S., Bloom, S. et al. (1980). Fatal myocardial infarction and the role of oral contraceptives. Am. J. Epidemiol, 111, 655

    PubMed  CAS  Google Scholar 

  13. Royal College of General Practitioners (1977). Mortality among oral contraceptive users. Lancet, 2, 727

    Google Scholar 

  14. Vessey, M., Doll, R., Peto, R., Johnson, B. and Wiggins, P. (1976). A long term follow- up study of women using different methods of contraception — an interim report. J. Biosoc. Sci., 8, 373

    Article  PubMed  CAS  Google Scholar 

  15. Vessey, M. P., McPherson, K. and Johnson, B. (1977). Mortality among women participating in the Oxford/Family Planning Association contraceptive study. Lancet, 2, 731

    Article  PubMed  CAS  Google Scholar 

  16. Vessey, M. P., McPherson, K. and Yeates, D. (1981). Mortality in oral contraceptive users. Lancet, 1, 549

    Article  PubMed  CAS  Google Scholar 

  17. Slone, D., Shapiro, S., Kaufman, D. W., Rosenberg, L., Miettinen, O. S. and Stolley, P. D. (1981). Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N. Engl. J. Med., 305, 420

    Article  PubMed  CAS  Google Scholar 

  18. Meade, T. W., Greenberg, G. and Thompson, S. G. (1980). Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations. Br. Med. J., 280, 1157

    Article  PubMed  CAS  Google Scholar 

  19. Collaborative Group for the study of stroke in young women (1973). Oral contraceptives and increased risk of cerebral ischaemia or thrombosis. N. Engl. J. Med., 288, 871

    Article  Google Scholar 

  20. Irey, N. N. and Norris, H. J. (1973). Intimal vascular lesions associated with female reproductive steroids. Arch. Pathol., 96, 227

    PubMed  CAS  Google Scholar 

  21. Irey, N. N., Manion, W. C. and Taylor, H. B. (1970). Vascular lesions in women taking oral contraceptives. Arch. Pathol., 89, 1

    PubMed  CAS  Google Scholar 

  22. Gammel, E. B. (1976). Intimal thickening in arteries of rats treated with synthetic sex hormones. Br. J. Exp. Pathol., 57, 248

    Google Scholar 

  23. Spain, D. M. (1978). Concerning the pathology of acute coronary heart disease in young women. In Oliver, M. F. (ed.) Coronary Heart Disease in Young Wome., pp. 61–70. (Edinburgh: Churchill Livingstone)

    Google Scholar 

  24. Weir, R. J., Briggs, E., Mack, A., Naiswith, L., Taylor, L. and Wilson, E. (1974). Blood pressure in women taking oral contraceptives. Br. Med. J., 1, 533

    Article  PubMed  CAS  Google Scholar 

  25. Stern, M. P., Brown, B. W., Haskell, W. L., Farquhar, J. W., Wehrle, C. L. and Wood, P. D. S. (1976). Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. J. Am. Med. Assoc., 235, 811

    Article  CAS  Google Scholar 

  26. Ostrander, L. D. Jr, Lamphiear, D. E., Block, W. D., Williams, G. W. and Carmen, W. J. (1980). Oral contraceptives and physiological variables. J. Am. Med. Assoc., 244, 677

    Article  CAS  Google Scholar 

  27. Bengtsson, C. (1977). Arterial hypertension as a risk factor for ischemic heart disease in women — results from a retrospective and from a prospective study. Acta Med. Scand., suppl. 602, 44

    Google Scholar 

  28. Kannel, W. B., Schwartz, M. J. and McNamara, P. M. (1969). Blood pressure and risk of coronary disease. The Framingham study. Dis. Chest, 56, 43

    Article  PubMed  CAS  Google Scholar 

  29. Kannel, W. B., Wolf, P. A., Verter, J. and McNamara, P. M. (1970). Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. J. Am. Med. Assoc., 214, 301

    Article  CAS  Google Scholar 

  30. Engel, H. J., Hundeshagen, H. and Lichtlen, P. (1977). Transmural myocardial infarction in young women taking oral contraceptives. Evidence of reduced regional coronary flow in spite of normal coronary arteries. Br. Heart J., 39, 477

    Article  PubMed  CAS  Google Scholar 

  31. Bolton, G. H., Hampton, J. R. and Mitchell, J. R. A. (1968). Effect of oral contraceptive agents on platelets and plasma phospholipids. Lancet, 1, 1336

    Article  PubMed  CAS  Google Scholar 

  32. Poller, L., Priest, C. M. and Thompson, J. M. (1969). Platelet aggregation during oral contraception. Br. Med. J., 4, 273

    Article  PubMed  CAS  Google Scholar 

  33. Elkeles, R. S., Hampton, J. R. and Mitchell, J. R. A. (1968). Effects of oestrogen on human platelet behaviour. Lancet, 2, 315

    Article  PubMed  CAS  Google Scholar 

  34. Poller, L. (1976). Oral contraception and blood clotting. In Gillingham, F. J., Maudsley, C. and Williams, A. E. (eds.) Strok., pp. 315–46. (Edinburgh: Churchill Livingstone)

    Google Scholar 

  35. Meade, T. W., Chakrabarti, R., Haines, A. P., Howarth, D. J., North, W. R. S. and Stirling, Y. (1977). Haemostatic, lipid and blood-pressure profiles of women on oral contraceptives containing 50 mg or 30 mg oestrogen. Lancet, 2, 948

    Article  PubMed  CAS  Google Scholar 

  36. Carvalho, A. C. A., Vaillancourt, R. A., Cabral, R. B., Lees, R. S. and Colman, R. W. (1977). Coagulation abnormalities in women taking oral contraceptives. J. Am. Med. Assoc., 237, 875

    Article  CAS  Google Scholar 

  37. Wessler, S. (1980). Thrombosis and sex hormones: a perplexing liaison. J. Lab. Clin. Med., 96, 759

    Google Scholar 

  38. Rosenberg, L., Armstrong, B. and Jick, H. (1976). Myocardial infarction and estrogen therapy in postmenopausal women. N. Engl. J. Med., 294, 1256

    Article  PubMed  CAS  Google Scholar 

  39. Pfeffer, R. I. and Van der Neort, S. (1976). Estrogen use and stroke risk in postmenopausal women. Am. J. Epidemiol., 103, 445

    PubMed  CAS  Google Scholar 

  40. Pfeffer, R. I., Whipple, G. H., Kurosaki, T. T. and Chapman, J. M. (1978). Coronary risk and estrogen use in postmenopausal women. Am. J. Epidemiol., 107, 479

    PubMed  CAS  Google Scholar 

  41. Rosenberg, L., Slone, D., Shapiro, S., Kaufman, D., Stolley, P. D. and Miettinen, O. S. (1979). Noncontraceptive estrogens and myocardial infarction in young women. J. Am. Med. Assoc., 244, 339

    Article  Google Scholar 

  42. Bain, C., Willett, W., Hennekens, C. H., Rosner, B., Belanger, C. and Speizer, F. E. (1980). Use of postmenopausal hormones and risk of myocardial infarction Circulation, 64, 42

    Article  Google Scholar 

  43. Adam, S., Williams, V. and Vessey, M. P. (1981). Cardiovascular disease and hormone replacement treatment: a pilot case control study. Br. Med. J., 282, 1277

    Article  CAS  Google Scholar 

  44. Gordon, T., Kannel, W. B., Hjortland, M. C. and McNamara, P. M. (1978). Menopause and coronary heart disease. The Framingham study. Ann. Intern. Med., 89, 157

    PubMed  CAS  Google Scholar 

  45. Jick, H., Dinan, B. and Rothman, K. J. (1978). Noncontraceptive estrogens and nonfatal myocardial infarction. J. Am. Med. Assoc., 239, 1407

    Article  CAS  Google Scholar 

  46. Jick, H., Dinan, B. and Rothman, K. J. (1978). Myocardial infarction and other vascular diseases in young women. J. Am. Med. Assoc., 240, 2548

    Article  CAS  Google Scholar 

  47. Ross, R. K., Paganni-Hill, A., Mack, T. M., Arthur, M. and Henderson, B. E. (1981). Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet, 1, 858

    Article  PubMed  CAS  Google Scholar 

  48. Wallace, R. B., Hoover, J., Sandler, D., Rifkind, B. M. and Tyroler, H. A. (1977). Altered plasma-lipids associated with oral contraceptive or oestrogen consumption. Lancet, 2, 11

    Article  PubMed  CAS  Google Scholar 

  49. Barrett-Connor, E., Brown, V., Turner, J., Austin, M. and Criqui, M. H. (1979). Heart disease risk factors and hormone use in postmenopausal women. J. Am. Med. Assoc., 24, 2167

    Article  Google Scholar 

  50. Hammond, C. B., Jelovsek, F. R., Lee, K. L., Creasman, W. T. and Parker, R. T. (1979). Effects of long-term estrogen replacement therapy. Am. J. Obstet. Gynecol., 133, 525

    PubMed  CAS  Google Scholar 

  51. Lindquist, O. and Bengtsson, C. (1980). Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Goteborg, Sweden. Scand. J. Clin. Invest., 40, 629

    Article  PubMed  CAS  Google Scholar 

  52. Oliver, M. F. and Boyd, G. S. (1961). Influence of reduction of urn lipids on prognosis of coronary heart-disease. Lancet, 2, 499

    Article  PubMed  CAS  Google Scholar 

  53. Stamler, J., Pick, R., Katz, L. N. et al. (1965). Effectiveness of estrogen for therapy of myocardial infarction in middle aged men. J. Am. Med. Assoc., 183, 632

    Google Scholar 

  54. Marmorstom, J., Moore, F. J., Hopkins, C. E., Kuzma, O. T. and Weiner, J. (1962). Clinical studies of long-term estrogen therapy in men with myocardial infarction. Proc. Soc. Exp. Biol., 110, 400

    Google Scholar 

  55. McDowell, F., Louis, S. and McDevitt, E. (1967). A clinical trial of premarin in cerebrovascular disease. J. Chron. Dis., 20, 679

    Article  Google Scholar 

  56. Veterans Administration Co-operative Urological Research Group (1967). Treatment and survival of patients with cancer of the prostate. Surg. Gynecol. Obstet., 124, 1011

    Google Scholar 

  57. Coronary Drug Project Research Group (1970). The Coronary Drug Project. Initial findings leading to modifications of its research protocol. J. Am. Med. Assoc., 214, 1303

    Article  Google Scholar 

  58. Coronary Drug Project Research Group (1973). The Coronary Drug Project. Findings leading to discontinuation of the 2.5 mg/day estrogen group. J. Am. Med. Assoc., 226, 652

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Queen’s University of Belfast, UK

    Robert W. Stout MD, FRCP (Professor of Geriatric Medicine)

Authors
  1. Robert W. Stout MD, FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1982 R. W. Stout

About this chapter

Cite this chapter

Stout, R.W. (1982). Oestrogens, progestogens and cardiovascular disease. In: Hormones and Atherosclerosis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6264-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6264-7_10

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6266-1

  • Online ISBN: 978-94-011-6264-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation